Business
Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
Gastroparesis slows the ability of the stomach to empty into the small intestine and thereby can delay absorption of oral medications into the bloodstream
About this update from Tonix Pharmaceuticals Holding Corp.
[{"type":"text","content":"Gastroparesis slows the ability of the stomach to empty into the small intestine and thereby can delay absorption of oral medications into the bloodstream Non-oral medications including nasal and injectables can bypass the digestive system providing better absorption and faster relief CHATHAM, N.J., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the launch of its new educational campaign, “Does Your Migraine Pill Work Every Time?” at this week’s PAINWeek National Conference in Las Vegas. The goal of the campaign is to educate patients and their healthcare providers on the benefits of non-oral migraine medications including nasal and injectable treatment options. Gastroparesis is a condition where the stomach empties food into the small intestine slower than normal. This can cause symptoms of nausea, vomiting, and abdominal pain. Many studies over the last 40 years show a connection between gastroparesis and migraine. Gastroparesis is common before, during, and sometimes in between migraine attacks. Gastroparesis can slow or even block the absorption of oral medications causing delayed, incomplete, or no migraine symptom relief. “Non-oral migraine medications, such as injectables and nasal sprays, do not rely on the digestive system to be absorbed and can offer the potential for faster relief from migraine symptoms in as little as 10 minutes,” said Deborah I. Friedman MD, MPH, FAHS, Board Certified Neuro-Ophthalmologist and Headache Medicine Specialist and Founding Director of the Headache and Facial Pain Program and Cerebrospinal Fluid Dynamics Program at the University of Texas Southwestern Medical Center. Dr. Friedman continued, “There are several options when it comes to nasal and injectable treatments, and I encourage patients to talk with their clinician about adding a non-oral medication to their treatment plan.” “Migraine often requires patients to advocate for themselves to develop an effective migraine treatment plan. Empowering patients to understand why they are experiencing delayed or inconsistent relief from oral medications and educating them on other migraine treatment options could ultimately improve their management of migrain...